Rare bacterial infectious disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:163582
Who is this for?
Show terms as
1FDA treatments6Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare bacterial infectious diseases encompass a broad and heterogeneous group of infections caused by uncommon bacterial pathogens that affect a small number of individuals within the general population. This Orphanet classification (ORPHA:163582) serves as a grouping category rather than a single discrete disease entity, covering a wide range of rare infections that can affect virtually any organ system in the body, including the skin, respiratory tract, gastrointestinal system, central nervous system, cardiovascular system, and musculoskeletal system. These infections may be caused by bacteria that are intrinsically rare, that infect humans only under unusual circumstances (such as zoonotic transmission), or that occur in specific geographic or environmental contexts. Clinical presentations vary enormously depending on the specific bacterial pathogen involved and the organ systems affected. Common features across many rare bacterial infections include fever, malaise, localized inflammation, and organ-specific symptoms such as pneumonia, meningitis, skin lesions, lymphadenopathy, or septicemia. Immunocompromised individuals may be at heightened risk for certain rare bacterial infections. Diagnosis often requires specialized microbiological testing, molecular diagnostics, or serological assays, as standard culture methods may not identify unusual pathogens. Treatment typically involves targeted antibiotic therapy, which may need to be guided by antimicrobial susceptibility testing given the unusual nature of the causative organisms. Some rare bacterial infections may require prolonged courses of antibiotics or combination therapy. Supportive care and management of complications are also important components of treatment. Due to the rarity of these conditions, clinical expertise may be limited, and management often benefits from consultation with infectious disease specialists. Research into many of these conditions is ongoing, and evidence-based treatment guidelines may be limited for the rarest entities within this group.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

1 available

Omeprazole

OMEPRAZOLE· PD-Rx Pharmaceuticals, Inc.

Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults

No actively recruiting trials found for Rare bacterial infectious disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare bacterial infectious disease community →

Specialists

6 foundView all specialists →
AP
Antonio Martorell, PhD
Specialist
PI on 3 active trials
DM
Daniel E Barquero Orias, MD
Specialist
PI on 1 active trial
DM
Daniel Ionescu, MD
SOLON, OH
Specialist
PI on 1 active trial
SC
Sharon Chen
Specialist
PI on 1 active trial931 Rare bacterial infectious disease publications
DM
Daniele o Provenzano, md
Specialist
PI on 1 active trial
YP
Yulian Konechnyi, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare bacterial infectious disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare bacterial infectious diseaseForum →

No community posts yet. Be the first to share your experience with Rare bacterial infectious disease.

Start the conversation →

Latest news about Rare bacterial infectious disease

No recent news articles for Rare bacterial infectious disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare bacterial infectious disease

What is Rare bacterial infectious disease?

Rare bacterial infectious diseases encompass a broad and heterogeneous group of infections caused by uncommon bacterial pathogens that affect a small number of individuals within the general population. This Orphanet classification (ORPHA:163582) serves as a grouping category rather than a single discrete disease entity, covering a wide range of rare infections that can affect virtually any organ system in the body, including the skin, respiratory tract, gastrointestinal system, central nervous system, cardiovascular system, and musculoskeletal system. These infections may be caused by bacteri

Which specialists treat Rare bacterial infectious disease?

6 specialists and care centers treating Rare bacterial infectious disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.